Immediate and long‐term effects of nicardipine, at rest and during exercise, in patients with coronary artery disease.

12 patients with documented coronary artery disease

Nicardipine 10 mg intravenously (at rest and during exercise) and oral nicardipine

Baseline/control exercise values without nicardipine

Haemodynamic parameters (heart rate, mean arterial pressure, cardiac index, systemic vascular resistance, left ventricular end diastolic pressure) and angina incidence during exercisesurrogate